innovation Archive

MiniMed 670G System Launches in the United States

I am pleased to share that today we announced the commercial launch of the MiniMed 670G system. Since earlier- than-expected FDA approval in September 2016, we have been working to ensure payer coverage, market and manufacturing readiness, as well as appropriate training of employees, clinicians, educators and patients on the new system. We also

Starting MiniMed 670G System Customer Training Phase

I’m pleased to announce the start of our Customer Training Phase for the MiniMed 670G system. During this phase, we’ll focus on on-boarding a small group of Priority Access Program participants at a select number of healthcare provider sites across the country. These sites will reflect diversity in terms of practice type, size, experience

First Live Experience of Sugar.IQ with Watson for People with Diabetes

I am excited to announce that Sugar.IQ with Watson, the first-of-its-kind cognitive app that helps detect important patterns and trends for people with diabetes, is now in live use for the first time. With app development now completed, we will conduct real-world testing of the final release candidate application with up to 100 MiniMed

DreaMed Captures A Physician’s Logic for an Artificial Pancreas Algorithm

In 2015, we took another step forward in the pursuit of developing an artificial pancreas. We joined forces with DreaMed Diabetes, a leading developer of diabetes treatment and management solutions, to incorporate DreaMed’s MD-Logic Artificial Pancreas algorithm into Medtronic’s future closed loop systems. Professor Moshe Phillip, M.D., Chairman and Chief Scientific Officer of DreaMed

Value-Based Healthcare: A New Approach to Diabetes Care

Value-based healthcare is driving change in the healthcare industry – emerging as a solution to rising healthcare costs, clinical inefficiency, and to make it easier for people to get the care they need. In the current fee-for-service model, healthcare providers are paid based on volume – number of patients seen, tests orders, and procedures

New Collaboration for the Next Generation of Professional CGM

I am very excited to share with you that we are collaborating with Qualcomm Life to develop future-generation continuous glucose monitoring (CGM) systems for people with type 2 diabetes. This collaboration – with an expert in developing reference designs for wireless, single-use and small integrated modules – enables us to create more affordable, easier-to-use